5 Best High Growth Healthcare Stocks to Buy

Page 1 of 5

In this article, we will take a look at the 5 high growth healthcare stocks to buy. To read our analysis of the recent market activity, you can go to the 13 High Growth Healthcare Stocks to Buy.

5. BeiGene, Ltd. (NASDAQ:BGNE)

Number of Hedge Fund Holders: 13

BeiGene, Ltd. (NASDAQ:BGNE) is a global biotechnology company that is discovering and developing innovative oncology treatments that are more affordable and accessible to cancer patients worldwide.

BeiGene, Ltd. (NASDAQ:BGNE) announced on November 17 that the European Commission has granted marketing authorization for BRUKINSA® (zanubrutinib) in combination with obinutuzumab for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma. This marks the fourth indication in the European Union  for BRUKINSA.

On November 8, BeiGene, Ltd. (NASDAQ:BGNE) released its financial results for Q3 2023. Its revenue increased by 102% y-o-y to $781 million, while it generated a net income of $215 million compared to a net loss of $558 million.

Citigroup analyst lowered the price target for BeiGene, Ltd. (NASDAQ:BGNE) shares from $290 to $285 and maintained a ‘Buy’ rating, in October. The target price represents a potential upside of 61.83% based on the share price on December 22, one of the highest on our list of 13 high growth healthcare stocks to buy.

Page 1 of 5